Nizar, S; Copier, J; Meyer, B; Bodman-Smith, M; Galustian, C; Kumar, D; Dalgleish, A (2009) T-regulatory cell modulation: the future of cancer immunotherapy? BRITISH JOURNAL OF CANCER, 100 (11). 1697 - 1703 (7). ISSN 0007-0920 https://doi.org/10.1038/sj.bjc.6605040
SGUL Authors: Bodman-Smith, Mark Duncan Copier, John Paul Dalgleish, Angus George

Preview

["document_typename_application/pdf; charset=binary" not defined] Published Version Download (136kB) | Preview

Item Type:	Article
Additional Information:	PubMed ID: 19384299
Keywords:	Animals, Antineoplastic Agents, Clinical Trials as Topic, Humans, Immunotherapy, Neoplasms, T-Lymphocytes, Regulatory, Science & Technology, Life Sciences & Biomedicine, Oncology, T-regulatory, tregs, immunotherapy, ANTITUMOR IMMUNE ACTIVITY, NON-HODGKIN-LYMPHOMA, PHASE-I TRIAL, METASTATIC MELANOMA, DENILEUKIN DIFTITOX, OVARIAN-CARCINOMA, CTLA-4 BLOCKADE, PERIPHERAL-BLOOD, DEPENDENT MANNER, TUMOR-REGRESSION, T-regulatory, tregs, immunotherapy
SGUL Research Institute / Research Centre:	Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title:	BRITISH JOURNAL OF CANCER
ISSN:	0007-0920
Related URLs:	Author
Dates:	Date Event 26 May 2009 Published
Web of Science ID:	WOS:000266517600001
	Download EPMC Full text (PDF)
	Download EPMC Full text (HTML)
URI:	https://openaccess.sgul.ac.uk/id/eprint/73
Publisher's version:	https://doi.org/10.1038/sj.bjc.6605040

Actions (login required)

Edit Item